These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11354376)

  • 1. Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-alpha.
    Kazimierczuk Z; Górska A; Switaj T; Lasek W
    Bioorg Med Chem Lett; 2001 May; 11(9):1197-200. PubMed ID: 11354376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structure and tumour necrosis factor-alpha production-enhancing properties of novel adamantylamino heterocyclic derivatives.
    Mauri JK; Lasek W; Górska A; Switaj T; Wamil M; Młynarczuk I; Kazimierczuk Z
    Anticancer Drug Des; 2001; 16(2-3):73-80. PubMed ID: 11962515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological properties of S-adamantylated heterocyclic compounds.
    Górska A; Switaj T; Młynarczukh I; Lasek W; Kazimierczuk Z
    Acta Pol Pharm; 2002; 59(6):415-7. PubMed ID: 12669761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of adamantyl substituted pyrimidines.
    Orzeszko B; Laudy AE; Starościak BJ; Orzeszko A; Kazimierczuk Z
    Acta Pol Pharm; 2004; 61(6):455-60. PubMed ID: 15794338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adamantylsulfanyl- and N-adamantylcarboxamido-derivatives of heterocycles and phenols: synthesis, crystal structure, tumor necrosis factor-alpha production-enhancing properties, and theoretical considerations.
    Maurin JK; Lasek W; Górska A; Switaj T; Jakubowska AB; Kazimierczuk Z
    Chem Biodivers; 2004 Oct; 1(10):1498-512. PubMed ID: 17191793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of TNF-alpha production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) - a novel immunomodulator with potential application in tumour immunotherapy.
    Lasek W; Switaj T; Sieńko J; Kasprzycka M; Basak G; Mikłaszewicz P; Maj M; Nowis D; Grzela T; Gołab J; Młynarczuk I; Jalili A; Kamińska B; Dziembowska M; Czajkowski K; Nowaczyk M; Górska A; Kazimierczuk Z
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):213-22. PubMed ID: 12203103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and bioactivities of novel 4,5,6,7-tetrahydrothieno[2,3-c]pyridines as inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.
    Fujita M; Seki T; Inada H; Ikeda N
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1607-11. PubMed ID: 12039573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-phenylimidazopyridines, a new series of Golgi compounds with potent antiviral activity.
    Banie H; Sinha A; Thomas RJ; Sircar JC; Richards ML
    J Med Chem; 2007 Nov; 50(24):5984-93. PubMed ID: 17973358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazo[1,2-a]pyridine derivatives as inhibitors of TNF-alpha expression in T cells.
    Rether J; Erkel G; Anke T; Bajtner J; Sterner O
    Bioorg Med Chem; 2008 Feb; 16(3):1236-41. PubMed ID: 18035545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
    Nantka-Namirski P; Kaczmarek L
    Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adamantane derivatives of biological interest. Synthesis and antiviral activity of 2-(1-adamantyl)imidazole derivatives.
    Pellicciari R; Fioretti MC; Cogolli P; Tiecco M
    Arzneimittelforschung; 1980; 30(12):2103-5. PubMed ID: 7194068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluations of condensed pyridine and condensed pyrimidine-based HMG-CoA reductase inhibitors.
    Suzuki M; Iwasaki H; Fujikawa Y; Sakashita M; Kitahara M; Sakoda R
    Bioorg Med Chem Lett; 2001 May; 11(10):1285-8. PubMed ID: 11392538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agents.
    Gueiffier A; Lhassani M; Elhakmaoui A; Snoeck R; Andrei G; Chavignon O; Teulade JC; Kerbal A; Essassi EM; Debouzy JC; Witvrouw M; Blache Y; Balzarini J; De Clercq E; Chapat JP
    J Med Chem; 1996 Jul; 39(14):2856-9. PubMed ID: 8709116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Oxo-1,4-dihydropyridines as selective CB₂ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.
    El Bakali J; Gilleron P; Body-Malapel M; Mansouri R; Muccioli GG; Djouina M; Barczyk A; Klupsch F; Andrzejak V; Lipka E; Furman C; Lambert DM; Chavatte P; Desreumaux P; Millet R
    J Med Chem; 2012 Oct; 55(20):8948-52. PubMed ID: 23017078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and pharmacological study of adamantyl benzene propanamines and propenamines].
    Pouli N; Fytas G; Foscolos GB; Kolocouris N; Marakos P; Vamvakides A
    Ann Pharm Fr; 1995; 53(4):163-9. PubMed ID: 7574270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioactivities of novel bicyclic thiophenes and 4,5,6,7-tetrahydrothieno[2,3-c]pyridines as inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.
    Fujita M; Seki T; Ikeda N
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1897-900. PubMed ID: 12113803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically active polycycloalkanes. 1. Antiviral adamantane derivatives.
    Aigami K; Inamoto Y; Takaishi N; Hattori K; Takatsuki A
    J Med Chem; 1975 Jul; 18(7):713-21. PubMed ID: 1171241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha.
    Hilmy KM
    Arch Pharm (Weinheim); 2004 Jan; 337(1):15-9. PubMed ID: 14760623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives.
    Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH
    Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.